Association between malignancy risk and Janus kinase inhibitors versus tumour necrosis factor inhibitors in Korean patients with rheumatoid arthritis: a nationwide population-based study.
Yeo-Jin SongSoo Kyung ChoSeung-Hun YouJeong-Yeon KimHyoungyoung KimSun-Young JungYoon-Kyoung SungPublished in: RMD open (2022)
Malignancy risk in Korean patients with RA was not increased with JAKi use compared with TNFi use.